Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Adipose-derived Mesenchymal Stem Cells Therapy

· CellinCells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Adipose-derived Mesenchymal Stem Cells Therapy, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars [Phase 1, Phase 2]

See pricing